The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

Cost to taxpayer is more than £21m, analysis shows, despite low supermarket prices for common painkiller ...

The painkiller commonly used to relieve headaches, toothache, back pain and cold symptoms, may speed up reaction times, boost ...

The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...